e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Infection in the immunocompromised host: infrequent aetiologies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Severe pulmonary infections due to biological therapy of rheumatic diseases
G. Lupkovics, C. Kiss, A. Lantos, E. Fajt, A. Paraczki, E. Tolnay (Torokbalint, Hungary)
Source:
Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies
Session:
Infection in the immunocompromised host: infrequent aetiologies
Session type:
Thematic Poster Session
Number:
2530
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Lupkovics, C. Kiss, A. Lantos, E. Fajt, A. Paraczki, E. Tolnay (Torokbalint, Hungary). Severe pulmonary infections due to biological therapy of rheumatic diseases. Eur Respir J 2011; 38: Suppl. 55, 2530
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Persistent fever and cytopenia in a patient with pulmonary tuberculosis
Related content which might interest you:
Candidosis due to treatment pulmonary diseases
Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities
Year: 2009
Impact of underlying respiratory diseases on clinical features and prognosis of chronic pulmonary aspergillosis
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015
Fungal VAP
Source: Eur Respir Mon 2011; 53: 122-137
Year: 2011
Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary diseases
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Bacterial infections in patients with acute exacerbation of chronic obstructive pulmonary diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 544s
Year: 2002
Cardiovascular implications of pulmonary hypertension due to chronic respiratory diseases
Source: Eur Respir Monogr 2020; 88: 167-183
Year: 2020
Prevalence and low diagnostics of chronic non-specific pulmonary diseases among pulmonary TB patients
Source: Annual Congress 2007 - Tuberculosis control in the penitentiary and civilian sector
Year: 2007
Treatment and prevention of acute respiratory viral infections in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Viral infections
Year: 2013
Bronchopulmonary infections cause exacerbation of chronic obstructive pulmonary diseases in the ICU
Source: Eur Respir J 2002; 20: Suppl. 38, 258s
Year: 2002
Pulmonary hypertension-specific therapy in patients with chronic respiratory insufficiency
Source: Eur Respir J 2014; 44: 821-822
Year: 2014
Pulmonary hypertension-specific therapy in patients with chronic respiratory insufficiency
Source: Eur Respir J 2014; 44: 819-821
Year: 2014
Infective exacerbations of chronic respiratory diseases
Source: ERS Course 2018 - Respiratory Infections
Year: 2018
Secondary pulmonary hypertension in chronic obstructive pulmonary disease and systemic lupus erythematosus- pathophysiology and treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 59s
Year: 2004
The treatment of acute respiratory viral infections in a patients with a chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Fungal, viral and other infections
Year: 2012
Chronic thromboembolic pulmonary hypertension
Source: Eur Respir Mon 2012; 57: 108-118
Year: 2012
Clinical features of chronic pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease
Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Year: 2008
The correlation between chronic obstructive pulmonary diseases and TB sequelae
Source: Eur Respir J 2003; 22: Suppl. 45, 344s
Year: 2003
Pulmonary involvement in rheumatological diseases in children
Source: Virtual Congress 2021 – Paediatric bronchology
Year: 2021
Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed?
Source: Eur Respir J 2002; 19: 966-975
Year: 2002
Dynamics etiologic spectrum of infectious exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept